FDA Approves Semaglutide As An Powerful Weight-loss Drug
Semaglutide has an outstanding weight-loss effect and is evaluated as the first time that humans have achieved weight-loss effects that could only be achieved by surgery before using drugs.
1Pick
関連記事一覧
アルツハイマー病治療薬承認に抗議、著名学者がFDA諮問委員を辞任
Bloomberg 129Picks

FDA、初のアルツハイマー治療薬を承認
The Wall Street Journal 2Picks
FDA、6月もサーチャージなし
Aviation Wire 2Picks
FDA approves first drug intended to slow cognitive decline caused by Alzheimer’s disease
Washington Post 2Picks
Wegovy (semaglutide) injection approved for chronic weight management.
医療従事者KeiSのブログ 2Picks
Hypertension and weight loss diet.
医療従事者KeiSのブログ 2Picks
アルツハイマー病薬承認で批判に直面するFDA
製薬業界の転職サイト Answers(アンサーズ) 2Picks
U.S. FDA approves Biogen Alzheimer's drug, hailed as 'a big day'
Reuters 1Pick
FDA approves Biogen's Alzheimer's drug, the first new therapy for the disease in nearly two decades
CNBC 1Pick
FDA to propose ban on menthol-flavored cigarettes
CNBC 1Pick